A protein linked to ALS and dementia, TDP43, plays a crucial role in regulating DNA mismatch repair, a process vital for maintaining genetic integrity and cellular health. This discovery, published in Nucleic Acids Research, could significantly impact our understanding of cancer and neurodegeneration. The study reveals that TDP43 regulates genes responsible for fixing DNA errors. When this protein is absent or overproduced, these repair genes become hyperactive, leading to neuronal damage and genome instability, which can contribute to cancer. The research team also uncovered a connection between TDP43 and cancer. Analysis of extensive cancer datasets showed that high levels of TDP43 correlate with increased mutation rates, indicating a broader biological role beyond ALS and FTD. This finding places TDP43 at the intersection of neurodegeneration and cancer, two of the most critical health challenges of our time. The study's findings open new avenues for treatment. By reducing overactive DNA repair in lab models, researchers partially reversed damage caused by TDP43 issues, suggesting that controlling DNA mismatch repair could be a promising therapeutic strategy. Collaborators on the study included Vincent Provasek, Suganya Rangaswamy, Manohar Kodavati, Joy Mitra, Vikas Malojirao, Velmarini Vasquez, Gavin Britz, and Sankar Mitra from Houston Methodist, Albino Bacolla and John Tainer from MD Anderson Cancer Center, Issa Yusuf and Zuoshang Xu from the University of Massachusetts, Guo-Min Li from UT Southwestern Medical Center, and Ralph Garruto from Binghamton University. The research was primarily supported by the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging of the National Institutes of Health (NIH), the Sherman Foundation Parkinson's Disease Research Challenge Fund, and internal funding from the Houston Methodist Research Institute. The study's implications are far-reaching, offering a deeper understanding of the complex relationship between TDP43, DNA repair, and disease development.
